Authors: Xiaozhao Wang, Jing Li, Zhengtao Luo, Zhimin Gao, Yongxin Huang, Jiamin Luo, Xinyi Wang, Yaru Zhang, Meiling Tan, Zhiyao Hou
Published: 2025-03-11
Source: Full article
AbstractInsufficient adenosine triphosphate (ATP) can reduce the synthesis of heat‐stress‐induced heat shock proteins (HSPs) to promote the efficiency of mild photothermal therapy (mPTT), thus the rational design of ATP‐exhausted strategy based on nanotechnology is an effective approach to resuscitate mPTT. Herein, Nd3+ doped nanocrystals (NaYF4:Nd@CaF2, Nd‐NCs) modified hollow mesoporous manganese oxide (H‐MnOx) nanocomposite (H‐MnOx@Nd‐NCs, MN) is synthesized, and loaded with glucose transporters (GLUTs) inhibitor KL‐11743, noted as MN‐KL nanozyme. In tumor microenvironment (TME), MN‐KL can react with overexpressed glutathione (GSH) to release KL‐11743, which can suppress the synthesis of intracellular ATP at the source by blocking glucose uptake to inhibit HSPs expression, meanwhile, MN‐KL catalyzes the production of ·O2−/1O2/·OH and lipid peroxidation (LPO) to cleave existing HSPs. Through a two‐pronged strategy with ATP inhibition and oxide accumulation, reducing the level of HSPs can be guaranteed for achieving efficient mPTT in both subcutaneous and in situ tumor models in mice. During this process, Nd‐NCs can absorb near‐infrared light and convert it into heat, and the quenched fluorescence of Nd‐NCs by H‐MnOx can be recovered through GSH‐triggered biodegradation in tumors, thus the modification of Nd‐NCs not only provides photothermal effect but also enables MN to own TME‐activated fluorescence imaging.